Search

everythinglearnresearchcommunity

for

Search:↓

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Kaposi's sarcoma lesions might originate from benign tissue changes.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Cutaneous epitheliotropic lymphoma in dogs is often misdiagnosed but can be treated with chemotherapy and alternative therapies.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

BST2 protein and certain T cells increase in early alopecia areata.

Alopecia areata involves unique activation of certain immune cells.

ePUKs could be valuable for regenerative medicine due to their wound healing abilities.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Apocrine type cutaneous mixed tumors often resemble hair follicles, sebaceous glands, and apocrine glands.

The skin of both rat strains showed similar lectin binding patterns.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.